PolyPid Azione

PolyPid Debiti verso fornitori

Il Debiti Commerciali di PolyPid (PYPD) al 10 ago 2026 è 2,86 Mio. USD. L'anno precedente, Debiti Commerciali era 2,41 Mio. USD — una variazione del 18,56% (superiore).

Debiti verso fornitori

2,86 Mio.USD

YoY

18,56%

Ultimo aggiornamento:

Debiti Commerciali di PolyPid ammonta a 2026 2,86 Mio. USD. Debiti Commerciali di PolyPid ammontava a 2025 2,41 Mio. USD. Diminuisce del 18,56% superiore rispetto all'anno precedente.
Access this data via the Eulerpool API

PolyPid Analisi delle Azioni

Cosa fa PolyPid? PolyPid Ltd is an innovative, emerging company in the field of biomedical technology based in Israel. The company was founded in 2008 and has since gained continuous recognition and growth. PolyPid's core business is the development and manufacturing of implantable polymer systems that contribute to wound healing. These polymer systems are specifically introduced into the affected area of the body and continuously release active substances to prevent infections and promote natural healing processes. PolyPid's business model is focused on effectively solving patients' problems. The company has developed a wide range of products and technologies that specifically target various medical applications. These include orthopedics, traumatology, urology, and gynecology. For orthopedics, PolyPid provides various products and technologies that can be used in knee and hip joint surgeries. These include antibiotic-releasing implants to prevent infections and resorbable bone fillers that allow for faster and more effective wound healing. In the field of traumatology, PolyPid manufactures polymer systems that are used in the treatment of bone fractures or other traumas. Here again, the polymer systems ensure continuous release of active substances to prevent infections and promote natural healing processes. PolyPid also offers innovative solutions for urology. Specifically, products are developed to combat urinary tract infections and promote faster wound healing after urological surgeries. For gynecology, PolyPid offers polymer systems that can be used particularly in the postoperative phase to prevent infections and achieve faster wound healing. PolyPid has earned an excellent reputation in the industry in recent years due to its consistent focus on innovation and quality. To continually improve their products, the company invests heavily in research and development and maintains close contact with medical institutions and professionals worldwide. PolyPid is an important partner in the field of biomedical technology and has already received numerous awards for its groundbreaking products and developments. Thanks to its focus on quality, reliability, and innovation, the company will continue to play a key role in the biomedical technology market. PolyPid è una delle aziende più popolari su Eulerpool.com.

Domande frequenti su PolyPid azioni

Debiti Commerciali di PolyPid è 2,86 Mio. USD nel 2026.

Il Debiti Commerciali di PolyPid è passato da 2,41 Mio. USD a 2,86 Mio. USD, con una variazione del 18,56 %. Il valore è superiore rispetto all'anno precedente.

Su Eulerpool è possibile consultare lo sviluppo storico completo del PolyPid di Debiti Commerciali dal 2006, con valori annuali, grafici e analisi dettagliate.

I debiti commerciali rappresentano il denaro dovuto ai fornitori per beni e servizi ricevuti. È un componente fondamentale della gestione del capitale di esercizio.

Il USD di Debiti Commerciali è un fattore chiave per gli investitori. I cambiamenti in questa metrica possono segnalare il miglioramento o il deterioramento dei fondamentali, impattando direttamente il prezzo delle azioni. Su Eulerpool puoi tracciare il PolyPid di Debiti Commerciali storicamente e in tempo reale.

Access this data via the Eulerpool API

Bilancio — PolyPid

Tutte le Metriche Finanziarie — PolyPid